[Skip to Navigation]
Sign In
JAMA Medical News

The latest news in clinical medicine, biomedical research, public health, and health policy

Medical News & Perspectives Deciding When It’s Better to Deprescribe Medicines Than to Continue Them
Medical News & Perspectives Highlights From AHA 2023—New Risk Calculator, Semaglutide and CVD, and More
Medical News & Perspectives FDA Green-Lights Tirzepatide, Marketed as Zepbound, for Chronic Weight Management
JAMA Associate Editor Gregory Marcus, MD Scott Morgan/American Heart Association